UCB (EBR:UCB) UCB Media Room: Share Repurchase Program 2022

Directive transparence : information réglementée

24/06/2022 20:05
https://mb.cision.com/Public/18595/3591268/a63dfcb3bb9bc1f5_800x800ar.png ** Share Repurchase Program 2022 to cover UCB's Long Term Incentive Plans f= or employees ------------------------------------------------------------ Brussels (Belgium), 24 June 2022 =E2=80=93 20:05 (CEST) =E2=80=93 Regulated= information=C2=A0 In application of article 7:215 of the Belgian Code of Companies and Associ= ations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =E2=80=9CCompany) (Euronext= Brussels: UCB) announces the launch of a share buy-back program (the =E2= =80=9CShare Repurchase Program 2022=E2=80=9D), effective as of 28 June 2022= .=C2=A0 The repurchase of UCB shares under this program intends to cover current an= d future obligations under UCB's Long Term Incentive Plans for its employee= s. UCB will continuously monitor both its current and future obligations un= der such plans in view of keeping an adequate level of treasury shares. Under this program, UCB may acquire from time to time its common stock, for= a maximum of 500 000 UCB shares. The share repurchases until 30 June 2022 = will be conducted under the terms and conditions approved by the extraordin= ary general shareholders=E2=80=99 meeting of the Company held on 30 April 2= 020, and under the terms and conditions approved by the extraordinary gener= al shareholders=E2=80=99 meeting of the Company held on 28 April 2022 for a= ll share repurchases as from 1 July 2022. The timing of the repurchase of s= hares pursuant to the program will depend on a variety of factors, includin= g market conditions. The program may be suspended or discontinued at any ti= me. UCB has requested a financial intermediary to repurchase UCB shares on its = behalf under the terms of a discretionary mandate agreement with initial va= lidity until 31 August 2022.=C2=A0 During the Share Repurchase Program 2022, regular updates will be published= in accordance with applicable legislation. In the framework of UCB=E2=80=99s ongoing cash and treasury shares manageme= nt, UCB may decide to enter into equity swap transactions, including during= the term of this Share Repurchase Program 2022. Any such transaction will = be reported in accordance with applicable legislation. This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . For further information, contact UCB:=C2=A0 Investor Relations Antje Witte=C2=A0 T +32 2 559 94 14 antje.witte@ucb.com Corporate Communications Laurent Schots=C2=A0 T+32 2 559 92 64 laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 600 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi= llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news =C2=A0 GenericFile 220624 - PR UCB Aandelen Inkoop Programma 2022 NL final (https://mb.cision.= com/Public/18595/3591268/a0f65bc615199129.pdf) GenericFile 220624 - PR Share Repurchase Program 2022 ENG final (https://mb.cision.com/= Public/18595/3591268/81b1c5959ff69722.pdf) GenericFile 220624 - PR UCB Programme de rachat d actions propres 2022 FR final (https:= //mb.cision.com/Public/18595/3591268/807f015a913e94a5.pdf) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x109264x1x6868579x2400= 0x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium

05/08/2022 20:05
05/08/2022 20:00
28/07/2022 07:00
20/07/2022 20:01
15/07/2022 20:00
08/07/2022 20:01
01/07/2022 20:03
24/06/2022 20:05
24/06/2022 20:00
24/06/2022 07:00